Free Trial

Innovative Eyewear (LUCY) Competitors

Innovative Eyewear logo
$6.56 -0.16 (-2.38%)
(As of 11/22/2024 ET)

LUCY vs. ICAD, OM, XAIR, SURG, BSGM, POCI, CODX, IRIX, DRIO, and ALUR

Should you be buying Innovative Eyewear stock or one of its competitors? The main competitors of Innovative Eyewear include iCAD (ICAD), Outset Medical (OM), Beyond Air (XAIR), SurgePays (SURG), BioSig Technologies (BSGM), Precision Optics (POCI), Co-Diagnostics (CODX), IRIDEX (IRIX), DarioHealth (DRIO), and Allurion Technologies (ALUR). These companies are all part of the "medical equipment" industry.

Innovative Eyewear vs.

Innovative Eyewear (NASDAQ:LUCY) and iCAD (NASDAQ:ICAD) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, dividends, risk, institutional ownership, profitability, community ranking, analyst recommendations, valuation and media sentiment.

iCAD has higher revenue and earnings than Innovative Eyewear. iCAD is trading at a lower price-to-earnings ratio than Innovative Eyewear, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Innovative Eyewear$1.15M13.92-$6.66M-$9.66-0.68
iCAD$17.32M2.36-$4.85M-$0.13-11.85

iCAD received 226 more outperform votes than Innovative Eyewear when rated by MarketBeat users. However, 100.00% of users gave Innovative Eyewear an outperform vote while only 62.13% of users gave iCAD an outperform vote.

CompanyUnderperformOutperform
Innovative EyewearOutperform Votes
2
100.00%
Underperform Votes
No Votes
iCADOutperform Votes
228
62.13%
Underperform Votes
139
37.87%

In the previous week, iCAD had 3 more articles in the media than Innovative Eyewear. MarketBeat recorded 3 mentions for iCAD and 0 mentions for Innovative Eyewear. iCAD's average media sentiment score of 0.59 beat Innovative Eyewear's score of 0.00 indicating that iCAD is being referred to more favorably in the news media.

Company Overall Sentiment
Innovative Eyewear Neutral
iCAD Positive

Innovative Eyewear has a beta of 2.8, suggesting that its share price is 180% more volatile than the S&P 500. Comparatively, iCAD has a beta of 1.47, suggesting that its share price is 47% more volatile than the S&P 500.

Innovative Eyewear presently has a consensus price target of $20.00, suggesting a potential upside of 204.88%. Given Innovative Eyewear's stronger consensus rating and higher probable upside, equities analysts clearly believe Innovative Eyewear is more favorable than iCAD.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Innovative Eyewear
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
iCAD
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

iCAD has a net margin of -17.81% compared to Innovative Eyewear's net margin of -514.01%. iCAD's return on equity of -15.65% beat Innovative Eyewear's return on equity.

Company Net Margins Return on Equity Return on Assets
Innovative Eyewear-514.01% -115.86% -105.40%
iCAD -17.81%-15.65%-12.52%

1.0% of Innovative Eyewear shares are owned by institutional investors. Comparatively, 24.6% of iCAD shares are owned by institutional investors. 6.4% of Innovative Eyewear shares are owned by insiders. Comparatively, 10.3% of iCAD shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

iCAD beats Innovative Eyewear on 11 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LUCY vs. The Competition

MetricInnovative EyewearOphthalmic goods IndustryMedical SectorNASDAQ Exchange
Market Cap$16.01M$11.43B$5.21B$8.85B
Dividend YieldN/A1.63%5.53%4.08%
P/E Ratio-0.6835.5584.1515.74
Price / Sales13.926.231,248.6188.25
Price / CashN/A17.4940.9736.92
Price / Book1.463.217.206.55
Net Income-$6.66M$224.33M$119.63M$226.22M
7 Day Performance-4.23%1.16%2.12%3.77%
1 Month Performance1.23%1.97%-2.43%4.64%
1 Year Performance-20.94%17.64%34.55%29.21%

Innovative Eyewear Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LUCY
Innovative Eyewear
1.3622 of 5 stars
$6.56
-2.4%
$20.00
+204.9%
-20.9%$16.01M$1.15M-0.689
ICAD
iCAD
0.5621 of 5 stars
$1.54
flat
N/A+18.5%$40.87M$17.32M-11.8567Analyst Upgrade
OM
Outset Medical
2.2883 of 5 stars
$0.84
+10.6%
$4.70
+461.1%
-83.6%$39.95M$114.73M-0.30520
XAIR
Beyond Air
4.3298 of 5 stars
$0.54
+3.8%
$3.67
+579.0%
-68.0%$38.98M$2.34M-0.3870
SURG
SurgePays
3.5223 of 5 stars
$1.75
-2.8%
$9.00
+414.3%
-72.4%$35.28M$137.14M-1.5522News Coverage
High Trading Volume
BSGM
BioSig Technologies
N/A$2.00
+3.6%
N/A-36.5%$34.26M$39,000.000.0050Positive News
POCI
Precision Optics
0.8435 of 5 stars
$5.11
+0.4%
N/A-15.5%$32.45M$19.10M-8.2480Gap Down
CODX
Co-Diagnostics
4.3977 of 5 stars
$1.01
-4.7%
$1.50
+48.5%
-19.8%$32.25M$7.32M-0.73100
IRIX
IRIDEX
0.7001 of 5 stars
$1.80
+4.7%
$2.00
+11.1%
-10.0%$29.95M$48.43M-2.60120
DRIO
DarioHealth
1.8809 of 5 stars
$0.84
+1.2%
$4.00
+373.5%
-15.5%$28.80M$23.05M-0.86200News Coverage
ALUR
Allurion Technologies
2.9839 of 5 stars
$0.43
-15.7%
$2.88
+568.8%
-88.3%$27.67M$53.47M-1.06501

Related Companies and Tools


This page (NASDAQ:LUCY) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners